Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
152.80    -0.20 (-0.13%)
Bid:
153.20
Ask:
153.60
Spread: 0.40 (0.261%)
Market Cap: £874.50m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Directorate change

19 Mar 2026 07:00

RNS Number : 2295X
Elementis PLC
19 March 2026
 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 of 16 April 2014 which forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

Appointment of Non-Executive Chair and Non-Executive Director

 

Elementis plc ("Elementis" or the "Group") is pleased to announce the appointment of Trudy Schoolenberg as Non-Executive Chair with effect from the end of the Annual General Meeting on 29 April 2026. Trudy will succeed John O'Higgins who announced in October 2026 that he would not stand for re-election.

Trudy has served as Non-Executive Senior Independent Director of Elementis since April 2022. She has around 35 years' experience in the chemicals, engineering and high‑performance product sectors, including ten years as a Senior Independent Director. Trudy also serves as Chair of Accsys Technologies PLC. Trudy's deep experience means she is exceptionally well placed to lead the Board of Elementis as it enters its next phase of growth. Trudy will continue as a member of the Remuneration Committee and will chair the Nomination Committee.

Christine Soden, Non-Executive Director, will be appointed as interim Senior Independent Director. Christine will continue in her current committee roles.

Elementis is also pleased to announce the appointment of Mike Humphrey as an Independent Non-Executive Director with effect from 29 April 2026, the date of its forthcoming AGM. Mike will bring significant leadership and operational experience in the specialty chemicals sector, having been Chief Executive Officer of Croda International plc from 1999 to 2011, playing a crucial role in reshaping its strategic focus on specialty markets. During Mike's tenure, Croda developed into a focused, innovation-led business with strong margins, global reach and a premium market positioning.

Trudy Schoolenberg, Chair designate and Non-Executive Director, said:

"I am delighted to be appointed Chair and look forward to working with Mike and the rest of the Board to support Luc van Ravenstein and the Leadership Team as they deliver our Elevate Elementis strategy."

Luc van Ravenstein, CEO, said:

"I would like to congratulate Trudy on her appointment as Chair. Her broad international experience, deep knowledge of the industry and respected position within Elementis make her the right leader at this important juncture for the business. I am also very pleased to welcome Mike, whose expertise will bring additional strength and depth to the Board."

There are no further disclosures required in respect of this announcement under UKLR.6.4.8.

The person responsible for the release of this announcement on behalf of Elementis plc is Hannah Constantine, Group General Counsel and Company Secretary.

Enquiries

Investors:

Hannah Constantine, Group General Counsel & Company Secretary, Elementis plc

Tel: +44 (0) 20 8148 5966

Zeeshan Maqbool, Investor Relations, Elementis plc

Tel: +44 (0) 7553 340 380

Press:

Martin Robinson/Giles Kernick, Teneo

Tel: +44 (0) 20 7353 4200

 

 

LEI: 549300LQIH685LI2ML36 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWRORNRUOAUR
Date   Source Headline
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing
14th Mar 20237:30 amRNSDirector Declaration
9th Mar 20232:50 pmRNSDirector/PDMR Shareholding
9th Mar 20232:47 pmRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSPreliminary results year ended 31 December 2022
1st Mar 20239:53 amRNSBlock listing Interim Review
1st Mar 20239:39 amRNSTotal Voting Rights
31st Jan 20233:04 pmRNSSale of Chromium business
19th Jan 20237:00 amRNSTrading Update
3rd Jan 20239:47 amRNSTotal Voting Rights
8th Dec 20222:10 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSSale of Chromium business
23rd Nov 20223:54 pmRNSHolding(s) in Company
16th Nov 20221:43 pmRNSHolding(s) in Company
10th Nov 20229:40 amRNSHolding(s) in Company
10th Nov 20227:00 amRNSDirectorate Change
1st Nov 20229:48 amRNSTotal Voting Rights
31st Oct 20223:23 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSQ3 Trading Update
18th Oct 20223:13 pmRNSHolding(s) in Company
3rd Oct 20229:39 amRNSTotal Voting Rights
29th Sep 202212:45 pmRNSDirector/PDMR Shareholding
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
22nd Sep 202211:17 amRNSDirector/PDMR Shareholding
21st Sep 20224:58 pmRNSDirector/PDMR Shareholding
21st Sep 20223:48 pmRNSDirector/PDMR Shareholding
6th Sep 202212:52 pmRNSDirector Declaration
5th Sep 20224:14 pmRNSAdditional Listing
1st Sep 202212:39 pmRNSHolding(s) in Company
1st Sep 20229:15 amRNSBlock listing Interim Review
1st Sep 20229:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.